TY - JOUR
T1 - Primary aldosteronism
T2 - A Japanese perspective
AU - Satoh, Fumitoshi
AU - Morimoto, Ryo
AU - Iwakura, Yoshitsugu
AU - Ono, Yoshikiyo
AU - Kudo, Masataka
AU - Takase, Kei
AU - Ito, Sadayoshi
PY - 2011/3
Y1 - 2011/3
N2 - Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.
AB - Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.
KW - Adrenal venous sampling
KW - Aldosterone producing adenoma
KW - Laparoscopic adrenalectomy
KW - Mineralocorticoid receptor antagonists
KW - Primary aldosreronism
UR - https://www.scopus.com/pages/publications/79956062163
UR - https://www.scopus.com/pages/publications/79956062163#tab=citedBy
U2 - 10.1007/s11154-011-9161-9
DO - 10.1007/s11154-011-9161-9
M3 - Review article
C2 - 21305358
AN - SCOPUS:79956062163
SN - 1389-9155
VL - 12
SP - 11
EP - 14
JO - Reviews in Endocrine and Metabolic Disorders
JF - Reviews in Endocrine and Metabolic Disorders
IS - 1
ER -
